Advertisement
FOCL vs SENS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOCL is a Buy and SENS is a Buy.
FOCL in +1.93% Uptrend, advancing for three consecutive days on October 26, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FOCL advanced for three days, in 185 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 56 cases where FOCL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on FOCL as a result. In 67 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for FOCL just turned positive on October 21, 2026. Looking at past instances where FOCL's MACD turned positive, the stock continued to rise in 31 of 41 cases over the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
FOCL moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for FOCL moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for FOCL entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. FOCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: FOCL's P/B Ratio (-61.199) is slightly lower than the industry average of (12.781). P/E Ratio (-4.019) is within average values for comparable stocks, (10.435). FOCL's Projected Growth (PEG Ratio) (8.100) is very high in comparison to the industry average of (2.016). Dividend Yield (0.000) settles around the average of (0.139) among similar stocks. P/S Ratio (1.919) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
SENS's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for SENS turned positive on October 28, 2026. Looking at past instances where SENS's MACD turned positive, the stock continued to rise in 37 of 40 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SENS's RSI Indicator exited the oversold zone, 39 of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on SENS as a result. In 70 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
SENS moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +17.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where SENS advanced for three days, in 198 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for SENS crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SENS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
SENS broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SENS entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.568) is normal, around the industry mean (4.201). P/E Ratio (-4.246) is within average values for comparable stocks, (1.335). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (9.058) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. SENS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SENS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
FOCL | SENS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 52 Fair valued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 99 | |
PRICE GROWTH RATING 1..100 | 42 | 35 | |
P/E GROWTH RATING 1..100 | 19 | 96 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SENS's Valuation (29) in the Electronic Components industry is in the same range as FOCL (52) in the Biotechnology industry. This means that SENS’s stock grew similarly to FOCL’s over the last 12 months.
SENS's Profit vs Risk Rating (100) in the Electronic Components industry is in the same range as FOCL (100) in the Biotechnology industry. This means that SENS’s stock grew similarly to FOCL’s over the last 12 months.
SENS's SMR Rating (99) in the Electronic Components industry is in the same range as FOCL (100) in the Biotechnology industry. This means that SENS’s stock grew similarly to FOCL’s over the last 12 months.
SENS's Price Growth Rating (35) in the Electronic Components industry is in the same range as FOCL (42) in the Biotechnology industry. This means that SENS’s stock grew similarly to FOCL’s over the last 12 months.
FOCL's P/E Growth Rating (19) in the Biotechnology industry is significantly better than the same rating for SENS (96) in the Electronic Components industry. This means that FOCL’s stock grew significantly faster than SENS’s over the last 12 months.
| FOCL | SENS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 87% |
| Stochastic ODDS (%) | 2 days ago 73% | 1 day ago 88% |
| Momentum ODDS (%) | 2 days ago 74% | 1 day ago 82% |
| MACD ODDS (%) | 2 days ago 76% | 1 day ago 90% |
| TrendWeek ODDS (%) | 2 days ago 77% | 1 day ago 83% |
| TrendMonth ODDS (%) | 2 days ago 85% | 1 day ago 85% |
| Advances ODDS (%) | 5 days ago 76% | 2 days ago 81% |
| Declines ODDS (%) | 12 days ago 84% | 9 days ago 85% |
| BollingerBands ODDS (%) | N/A | 1 day ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 1 day ago 82% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FOCL’s FA Score shows that 1 FA rating(s) are green while SENS’s FA Score has 1 green FA rating(s).
- FOCL’s FA Score: 1 green, 4 red.
- SENS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FOCL’s TA Score shows that 4 TA indicator(s) are bullish while SENS’s TA Score has 5 bullish TA indicator(s).
- FOCL’s TA Score: 4 bullish, 4 bearish.
- SENS’s TA Score: 5 bullish, 5 bearish.
Price Growth
FOCL (@Medical Distributors) experienced а +0.24% price change this week, while SENS (@Medical/Nursing Services) price change was +26.63% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +1.68%. For the same industry, the average monthly price growth was -7.47%, and the average quarterly price growth was -23.70%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.04%. For the same industry, the average monthly price growth was -8.74%, and the average quarterly price growth was -9.59%.
Reported Earning Dates
FOCL is expected to report earnings on Nov 05, 2026.
SENS is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Medical Distributors (+1.68% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
@Medical/Nursing Services (+0.04% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
FOCL and
Correlation & Price change
A.I.dvisor tells us that FOCL and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FOCL and AORT's prices will move in lockstep.
| Ticker / NAME | Correlation To FOCL | 1D Price Change % | ||
|---|---|---|---|---|
| FOCL | 100% | +0.24% | ||
| AORT - FOCL | 29% Poorly correlated | -3.67% | ||
| UFPT - FOCL | 20% Poorly correlated | -3.00% | ||
| SENS - FOCL | 20% Poorly correlated | -2.46% | ||
| STXS - FOCL | 16% Poorly correlated | -5.21% | ||
| HBIO - FOCL | 11% Poorly correlated | +1.14% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GCAD | 50.01 | 1.55 | +3.21% |
| Gabelli Commercial Aerospace and Defense ETF (GCAD) | |||
| RDVI | 28.25 | 0.24 | +0.86% |
| FT Vest Rising Dividend Achievers Target Income ETF (RDVI) | |||
| IBIH | 25.38 | 0.09 | +0.37% |
| iShares iBonds Oct 2031 Term TIPS ETF (IBIH) | |||
| IBMR | 25.17 | N/A | N/A |
| iShares iBonds Dec 2029 Term Muni Bond ETF (IBMR) | |||
| RNMN | 26.01 | N/A | N/A |
| RiverNorth Market Neutral ETF (RNMN) | |||